U.S. Capital Markets Stock News

Cohen & Steers plans to convert its Future of Energy Fund into an ETF. The shift aligns the firm with a broader move by traditional asset managers toward ETF structures. The conversion responds to changing investor preferences around access, fees, and trading flexibility. Cohen & Steers, listed as NYSE:CNS, is moving its Future of Energy Fund into an ETF format at a time when investors are paying close attention to listed asset managers and their product line ups. The shares most recently...

VeriSign, Inc. recently reported its fourth-quarter and full-year 2025 results, showing higher sales and net income year over year, while also announcing a quarterly dividend increase to US$0.81 per share and updating investors on progress under its long-running share repurchase program. Beyond the headline growth in revenue and earnings, the combination of a higher dividend and continued buybacks highlights management’s emphasis on returning cash to shareholders alongside its core internet...

Paramount Skydance (PSKY) has caught investor attention after its recent performance, with the share price last closing at US$11.01 and short term returns showing a mix of modest gains and declines across different time frames. See our latest analysis for Paramount Skydance. Those small recent share price gains, including a 1-day share price return of 1.57% and 7-day return of 2.42%, sit against a weaker backdrop, with a 30-day share price return showing a 9.38% decline and a 90-day share...

If you are wondering whether Neurocrine Biosciences is fairly priced or offering value right now, you are not alone. This article is designed to help you frame that question clearly. The stock last closed at US$137.44, with returns of 3.6% over 30 days and 17.3% over 1 year. These figures can change how investors think about both its potential upside and its risk. Recent news coverage has focused on Neurocrine Biosciences as a key player in the US pharmaceuticals and biotech space, with...

If you are wondering whether Atlassian shares are starting to look interesting at today’s price, this article will walk through what the current market value actually reflects and what it might be missing. Atlassian’s share price closed at US$86.97, with returns of a 17.2% decline over 7 days, 40.6% decline over 30 days, 43.8% decline year to date and 72.7% decline over the past year. Even the 3 year and 5 year returns of 53.6% decline and 65.3% decline respectively show how much sentiment...

If you are wondering whether Syndax Pharmaceuticals at US$21.71 is offering good value today, you are not alone. This article is here to unpack that question calmly and clearly. The stock has returned 6.3% over the last 7 days, 4.8% over 30 days, 1.9% year to date and 46.1% over the past year. However, the 3 year and 5 year returns of negative 16.5% and negative 5.0% show a more mixed longer term picture. These moves have arrived alongside ongoing interest in Syndax Pharmaceuticals' pipeline...

How Avantor's FY 2025 Numbers Set the Stage for the Next Chapter Avantor (AVTR) just posted its FY 2025 third quarter results with revenue of US$1,623.8 million, a basic EPS loss of US$1.04 and net income loss of US$711.8 million, putting a sharp spotlight on profitability. The company has seen quarterly revenue move from US$1,714.4 million in Q3 2024 to US$1,686.6 million in Q4 2024, then to US$1,581.4 million and US$1,683.4 million in Q1 and Q2 2025, with EPS shifting from US$0.08 to...

Navitas Semiconductor (NVTS) has introduced a 10 kW all‑GaN DC‑DC power platform targeting next‑generation AI data centers, offering up to 98.5% peak efficiency, 1 MHz switching frequency, and high power density in a compact full‑brick module. See our latest analysis for Navitas Semiconductor. At a share price of $8.76, Navitas has had a mixed few months, with a 7 day share price return of 6.83% alongside a 30 day share price decline of 16.01%. Its 1 year total shareholder return of 207.37%...

If you are wondering whether Pathward Financial's current share price still offers value, it helps to first see how its market price lines up with what the business might be worth. The stock last closed at US$89.59, with returns of 21.8% over the past month, 24.7% year to date and 14.0% over the last year, which can change how investors think about both upside and risk. Recent news coverage has focused on Pathward Financial's position in the U.S. banking sector and how its business model...

If you are wondering whether Nu Holdings is still good value after its strong run, you are not alone. The stock has quickly become a talking point for many growth focused investors. The share price recently closed at US$17.41, with total returns of 2.3% over the past week, 2.2% over the past month, 2.3% year to date and 27.6% over the last year, while the 3 year return sits at 232.3%. This naturally raises questions about what is already priced in. Recent news flow has centered on Nu...

Federal National Mortgage Association (FNMA) has just posted its FY 2025 third quarter numbers, with revenue of US$7.0b and EPS of US$0.66 setting the tone for the latest update. Over recent quarters, revenue has moved from US$8.0b in FY 2024 Q2 to US$7.4b in Q3 and US$7.8b in Q4, then to US$7.2b in FY 2025 Q1, US$6.5b in Q2 and US$7.0b in Q3. EPS has ranged from US$1.50 in FY 2024 Q2 and US$0.69 in Q3 to close to zero in late 2024 and early 2025, before landing at US$1.19 in FY 2025 Q2 and...

If you are wondering whether Universal's share price reflects what the business is worth, or if the market is overlooking something important, this article is for you. The stock last closed at US$52.87, with returns of a 10% decline over 7 days, a 2.6% decline over 30 days, 0.6% year to date, 4.8% over 1 year, 19.1% over 3 years and 36.7% over 5 years. Recent share price moves have brought Universal back onto investors' radar, especially for those reassessing risk and reward at current...

Latest Earnings Snapshot Tower Semiconductor (NasdaqGS:TSEM) has posted its FY 2025 third quarter numbers with revenue of US$395.7 million and basic EPS of US$0.48, giving investors a clear read on how the year is shaping up. The company has seen revenue move from US$351.2 million in Q2 2024 to US$395.7 million in Q3 2025, while quarterly basic EPS has ranged from US$0.48 to US$0.49 over that period, alongside trailing 12 month revenue of about US$1.5 billion and basic EPS of roughly US$1.75...

In early February 2026, Expro unveiled Solus™, a high-debris single shear and seal ball valve system that replaces traditional two-valve subsea well access configurations, offering enhanced safety, flexibility, and reduced complexity for offshore oil and gas operations. By combining shear-and-seal capability in a single NACE-compliant valve already deployed in the Gulf of Mexico and the North Sea, Solus™ underscores Expro’s push toward more efficient subsea intervention and well abandonment...

Earlier this week, Community Health Accreditation Partner (CHAP) awarded Aveanna Home Health and Hospice a Disease Program Certification for Heart Failure, recognizing compliance with nationally accepted quality metrics and advanced clinician education standards across its Heartways program. This certification highlights Aveanna’s emphasis on specialized, clinically rigorous heart failure care in the home setting, which could strengthen its position with patients, payers, and referral...

Why Philip Morris International (PM) Is Back in Focus After Its Latest Earnings Philip Morris International (PM) is back on many investors radar after reporting fourth quarter and full year 2025 results, raising 2026 EPS growth guidance, and highlighting the growing role of smoke free products. See our latest analysis for Philip Morris International. The earnings beat, higher 2026 EPS growth guidance and growing share of smoke free products have coincided with a 12.78% 1 month share price...

The Coca-Cola Company has released its fourth-quarter and full-year 2025 results, reporting Q4 sales of US$11,822 million and net income of US$2,271 million, alongside a near US$1 billion impairment on its BodyArmor sports drink brand. The update also confirmed a leadership handover from CEO James Quincey to Henrique Braun and set 2026 guidance for 4% to 5% organic revenue growth and 7% to 8% comparable earnings growth, framing how the business plans to respond to mixed regional trends and...

Oshkosh Corporation recently reported its fourth-quarter and full-year 2025 results, issued 2026 earnings guidance of approximately US$10.90 diluted EPS, raised its quarterly dividend to US$0.57 per share, and confirmed completion of a long-running share repurchase program totaling about US$1.57 billions since 2015. Taken together, these updates highlight how Oshkosh is balancing reinvestment with increasing cash returns to shareholders, while offering clearer visibility into its expected...

Alexander's Inc. (NYSE:ALX) reported lower quarterly and full year net income and funds from operations. Management highlighted improving New York office occupancy as a key operational development. The CEO pointed to share buybacks as a current priority, reflecting views on the stock's valuation. For investors watching real estate investment trusts, Alexander's sits in an interesting spot. The stock trades at $230.02 and is up 25.6% over the past year and 29.0% over the past three years,...

Cisco Systems stock: recent performance snapshot Cisco Systems (CSCO) has quietly moved higher, with the share price up 15.6% over the past month and 10.5% in the past 3 months, following a 40.1% total return over the past year. See our latest analysis for Cisco Systems. The recent 15.6% 30 day share price return and 12.5% year to date share price return, alongside a 40.1% 1 year total shareholder return, point to momentum building rather than fading for Cisco Systems at its current US$85.54...

Toro (TTC) has been drawing attention after recent share price moves, with the stock up over the past week, month and past 3 months. Investors are weighing this momentum against the company’s current fundamentals. See our latest analysis for Toro. Looking beyond the recent rally, Toro’s share price has recorded a 39.25% 3 month share price return and a 24.36% year to date share price return, while the 1 year total shareholder return of 28.50% contrasts with a 3 year total shareholder return...

Medpace Holdings stock overview Medpace Holdings (MEDP) has recently drawn investor attention after a period of weaker share performance, with the stock showing declines over the past week, month and past 3 months alongside a lower year to date return. See our latest analysis for Medpace Holdings. At a share price of US$423.93, Medpace’s recent pullback, including a 30 day share price return of a 29.25% decline, contrasts with its 1 year total shareholder return of 25.99%. This hints at...

If you are wondering whether MongoDB's current share price reflects its long term potential, you are not alone. A closer look at its valuation can help frame that question more clearly. The stock last closed at US$364.46, with returns of 8.0% over 7 days, a 12.8% decline over 30 days, a 8.8% decline year to date, a 24.6% gain over 1 year, a 56.1% gain over 3 years, and a 11.3% decline over 5 years. Recent coverage around MongoDB has focused on its position in cloud based databases and how...

If you are wondering whether Clear Channel Outdoor Holdings at around US$2.37 is priced attractively or already reflects its prospects, you are in the right place. The stock has recently shown strong momentum, with returns of 10.7% over 7 days, 15.6% over 30 days, 11.8% year to date and 76.9% over the past year, as well as 31.7% over 3 years and 11.3% over 5 years. Recent news around Clear Channel Outdoor Holdings has focused on its position in the out of home advertising market, including...